Found 215 matching trials
500mg Fulvestrant Versus Exemestane in MBC N/A 500mg Fulvestrant versus Exemestane in MBC...
Learn More & Join Trial
PAlbociclib and Circulating Tumor DNA for ESR1 Mutation Detection PHASE3 This study is a randomized, open-label, multicentric, phase III trial condu...
Show More Location
Centre Hospitalier Universitaire
Learn More & Join Trial
A Phase II Study of Zongertinib Plus Fulvestrant in Participants With HR-positive/HER2-negative Advanced Breast Cancer Harboring HER2 Mutations. PHASE2 An international, multicenter, two-stage optimal Simon's design, single-arm...
Show More Location
Multiple Locations
Learn More & Join Trial
Study to Assess the Efficacy and Safety of Alpelisib Plus Fulvestrant in Participants With HR-positive (HR+), HER2-negative, Advanced Breast Cancer After Treatment With a CDK4/6 Inhibitor and an Aromatase Inhibitor. PHASE3 The purpose of this study is to complement Study CBYL719C2301 (SOLAR-1) and...
Show More Status
Active Not Recruiting
Location
Novartis Investigative Site
Learn More & Join Trial
Safety Study of Enzalutamide (MDV3100) in Patients With Incurable Breast Cancer PHASE1 The purpose of this study is to determine the safety, tolerability and phar...
Show More Location
ATTN-Research Pharmacist
Learn More & Join Trial
Anastrazole, Fulvestrant & Abemaciclib for HR+HER2- Metastatic Breast Cancer PHASE2 This is a phase 2, open-label, singled-arm clinical trial determining effic...
Show More Location
Chao Family Comprehensive Cancer Center, University of California, Irvine
Learn More & Join Trial
Gedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for the Treatment of Patients With Advanced or Metastatic HR+/HER2- Breast Cancer (VIKTORIA-1) PHASE3 This is a Phase 3, open-label, randomized, clinical trial evaluating the ef...
Show More Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Learn More & Join Trial
Precision Treatment of Recurrent/Metastatic Salivary Gland Carcinoma Guided by Molecular Typing PHASE2 Patients with salivary gland carcinoma were divided into groups according t...
Show More Learn More & Join Trial
Fulvestrant 500mg With Exemestane Endocrine Therapy for Postmenopausal Advanced Breast Cancer Patients PHASE2 A Randomized, Open label, Parallel-group, Multi-center study. Eligible pati...
Show More Location
National Cancer Institute, Cancer Hospital Chinese Academy of Medical Sciences
Learn More & Join Trial
Study to Evaluate the Safety, Tolerability, and PK of Fulvestrant After IM Administration PHASE1 Clinical study designed to assess the plasma pharmacokinetic profile and to...
Show More Location
Collaborative Neuroscience Network, LLC
Learn More & Join Trial